-
Abbott Laboratories Analyst Is Bullish About MedTech, Non-MedTech Growth
Tuesday, October 8, 2024 - 11:59am | 286Read More...Abbott Laboratories’s (NYSE:ABT) MedTech portfolio is growing at a CAGR (compounded annual growing rate) of 11%-13%. The company’s non-MedTech operations are expanding by low-to-mid single-digit percentages, according to Oppenheimer. Analyst Suraj Kalia initiated coverage of Abbott...
-
GE HealthCare Technologies Is Innovating An $84B Market And This Analyst Is Bullish
Tuesday, May 16, 2023 - 10:26am | 269Read More...Shares of GE HealthCare Technologies Inc (NASDAQ: GEHC) rose in early trading on Tuesday, just days after the company presented at the European Society for Therapeutic Radiology and Oncology 2023 Congress. Oppenheimer analyst Suraj Kalia initiated coverage of GE HealthCare Technologies with an...
-
Intuitive Surgical Soars On Stellar Q1 Results: Analysts Boost Price Targets Amid Robust Procedure Growth
Wednesday, April 19, 2023 - 12:06pm | 619Read More...Shares of Intuitive Surgical, Inc. (NASDAQ: ISRG) surged in after-hours trading on Tuesday, following the release of the company’s upbeat results for the first quarter. RBC Capital Markets On Intuitive Surgical Analyst Shagun Singh maintained an Outperform rating, while raising the price...
-
Northland Analyst: Spectranetics Guidance 'Sets Off Alarm Bells...'
Friday, July 24, 2015 - 2:26pm | 320Read More...Shares of Spectranetics Corp (NASDAQ: SPNC) are down more than 33 percent after the company reported its second quarter results on Thursday evening. The stock is tumbling despite a beat in earnings, on the back of a guidance cut. Management trimmed its full year 2015 revenue guidance to a range...
-
Cynosure Targets Raised At Northland Capital On Potential Vaginal Atrophy Treatment
Thursday, June 25, 2015 - 3:21pm | 337Read More...In a report issued Thursday, Northland Capital Markets analyst Suraj Kalia reiterated an Outperform rating on Cynosure, Inc. (NASDAQ: CYNO), while raising his price target from $42 to $46. The surge in the price target was driven by the firm’s sum of the parts analysis on the MonaLisa...
